Holdings of Nan Fung Group Holdings Ltd
22 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 86.4 % of the equity sleeve
Sector breakdown
- Materials 4.6 %
- Health care 2.8 %
- Unattributed 92.5 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 95.3 %
- DK 2.8 %
- NL 1.9 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 20 | 104.6M $ | 95.30 % |
| 2 | DK | 1 | 3.1M $ | 2.83 % |
| 3 | NL | 1 | 2M $ | 1.86 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Evommune Inc | 1,441,032 | 33.1M $ | |
| 2 | MapLight Therapeutics Inc | 971,253 | 19.7M $ | |
| 3 | LB Pharmaceuticals Inc | 630,657 | 15.6M $ | |
| 4 | Incyte Corp | 53,742 | 5.1M $ | |
| 5 | BEONE MEDICINES LTD | 15,722 | 4.7M $ | |
| 6 | Rhythm Pharmaceuticals Inc | 49,120 | 4.3M $ | |
| 7 | Celcuity Inc | 28,300 | 3.2M $ | |
| 8 | Ascendis Pharma A/S | 13,600 | 3.1M $ | |
| 9 | Procore Technologies Inc | 53,299 | 3M $ | |
| 10 | Madrigal Pharmaceuticals Inc | 5,672 | 3M $ | |
| 11 | Kymera Therapeutics Inc | 30,875 | 2.6M $ | |
| 12 | ACADIA Pharmaceuticals Inc | 102,984 | 2.3M $ | |
| 13 | Argenx SE | 2,800 | 2M $ | |
| 14 | Revolution Medicines Inc | 19,253 | 1.9M $ | |
| 15 | Recursion Pharmaceuticals Inc | 595,287 | 1.8M $ | |
| 16 | Insmed Inc | 6,580 | 1.1M $ | |
| 17 | iShares Ethereum Trust ETF | 50,549 | 800.2K $ | |
| 18 | Harmony Biosciences Holdings Inc | 27,049 | 757.6K $ | |
| 19 | Entrada Therapeutics Inc | 49,082 | 619.4K $ | |
| 20 | iShares Bitcoin Trust ETF | 15,968 | 613.5K $ | |
| 21 | Rani Therapeutics Holdings Inc | 493,584 | 362.7K $ | |
| 22 | BOLT BIOTHERAPEUTICS INC | 29,250 | 118.2K $ |